Financials
- Market Capitalization 49.4 M
- Employee 21
- Founded 2015
- CEO N/A
- Website www.inmunebio.com
- Headquarter Nevada, United States
- FIGI BBG00LW94L98
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.84
ratio cours/chiffre d'affaires
772.44
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4156 | MREO Mereo BioPharma Group plc - American Depositary Shares | 0.32 USD | -8.57% | -20.00% | +14.29% | -84.00% | 51.10 M USD | ||
| 4173 | ELTX Elicio Therapeutics, Inc. - Common Stock | 1.88 USD | -0.53% | -1.05% | -8.74% | -81.20% | 49.41 M USD | ||
| 4177 | ANVS Annovis Bio, Inc. Common Stock | 1.14 USD | -6.56% | -5.00% | +2.70% | -30.49% | 48.57 M USD | ||
| 4181 | SER Serina Therapeutics, Inc. Common Stock | 1.90 USD | -5.00% | -6.40% | -16.67% | +14.11% | 48.26 M USD |